JP2016535769A5 - - Google Patents

Download PDF

Info

Publication number
JP2016535769A5
JP2016535769A5 JP2016551037A JP2016551037A JP2016535769A5 JP 2016535769 A5 JP2016535769 A5 JP 2016535769A5 JP 2016551037 A JP2016551037 A JP 2016551037A JP 2016551037 A JP2016551037 A JP 2016551037A JP 2016535769 A5 JP2016535769 A5 JP 2016535769A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
represents hydrogen
here
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2016551037A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016535769A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/073800 external-priority patent/WO2015067651A1/de
Publication of JP2016535769A publication Critical patent/JP2016535769A/ja
Publication of JP2016535769A5 publication Critical patent/JP2016535769A5/ja
Ceased legal-status Critical Current

Links

JP2016551037A 2013-11-08 2014-11-05 キマーゼ阻害薬としての置換されているウラシル類 Ceased JP2016535769A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13192183 2013-11-08
EP13192183.5 2013-11-08
PCT/EP2014/073800 WO2015067651A1 (de) 2013-11-08 2014-11-05 Substituierte uracile als chymase inhibitoren

Publications (2)

Publication Number Publication Date
JP2016535769A JP2016535769A (ja) 2016-11-17
JP2016535769A5 true JP2016535769A5 (OSRAM) 2017-12-14

Family

ID=49582563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016551037A Ceased JP2016535769A (ja) 2013-11-08 2014-11-05 キマーゼ阻害薬としての置換されているウラシル類

Country Status (7)

Country Link
US (2) US9695131B2 (OSRAM)
EP (1) EP3066096A1 (OSRAM)
JP (1) JP2016535769A (OSRAM)
CN (1) CN105873919A (OSRAM)
CA (1) CA2929763A1 (OSRAM)
HK (1) HK1224288A1 (OSRAM)
WO (1) WO2015067651A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3066097T1 (sl) * 2013-11-08 2017-12-29 Bayer Pharma Aktiengeselschaft Soli 1-(3-metil-2-okso-2,3-dihidro-1,3-benzoksazol-6-il)-2,4-diokso-3-((1r)-4 -(trifluormetil)-2,3-dihidro-1H-inden-1-il)-1,2,3,4-tetrahidropirimidin- 5-ogljikove kisline
EP3338780A1 (de) 2016-12-20 2018-06-27 Bayer Pharma Aktiengesellschaft Verwendung von chymaseinhibitoren zur behandlung von endometriose, post-operativer fibrose und erkrankungen die durch fibrosebildung gekennzeichnet sind
CA3061444A1 (en) * 2017-04-27 2018-11-01 Bayer Aktiengesellschaft Selective adrenoreceptor .alpha.2c receptor antagonists alone, or in combination with chymase inhibitors for use in the treatment and/or prophylaxis of peripheral artery diseases (pad)
CN113811530B (zh) * 2019-07-03 2022-07-19 南京明德新药研发有限公司 作为糜酶抑制剂的嘧啶酮类化合物及其应用
GB201918414D0 (en) * 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
WO2022135514A1 (zh) * 2020-12-25 2022-06-30 广东东阳光药业有限公司 多取代的尿嘧啶衍生物及其用途
WO2022135502A1 (zh) * 2020-12-25 2022-06-30 广东东阳光药业有限公司 多取代的尿嘧啶衍生物及其用途
WO2022135534A1 (zh) * 2020-12-25 2022-06-30 广东东阳光药业有限公司 取代的含氮双环化合物及其用途
CN119278042A (zh) 2022-04-05 2025-01-07 索克普拉健康与人文科学公司 用于血栓性或血栓栓塞性病症中血栓的选择性溶解的糜蛋白酶抑制剂
CN118994100A (zh) * 2023-05-22 2024-11-22 苏州大学 一种二酮类化合物及其制备方法与应用
CN119019341B (zh) * 2023-05-23 2025-11-18 苏州大学 一种腈类化合物及其制备方法与应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69519921T2 (de) * 1994-07-29 2001-06-13 Suntory Limited, Osaka Imidazolidin-derivate und ihre verwendung
KR100400639B1 (ko) * 1995-04-27 2003-12-31 미쯔비시 웰 파마 가부시키가이샤 복소환식아미드화합물및그의의약용도
EP0936216A4 (en) * 1996-09-06 2003-01-02 Nippon Kayaku Kk NOVEL ACETAMIDE DERIVATIVES AND PROTEASE INHIBITORS
JPH10195063A (ja) 1996-10-21 1998-07-28 Dai Ichi Seiyaku Co Ltd エチニルチアゾール誘導体
WO1998018794A1 (en) * 1996-10-25 1998-05-07 Yoshitomi Pharmaceutical Industries, Ltd. Novel heterocyclic amide compounds and medicinal uses thereof
CA2321146A1 (en) * 1998-02-17 1999-08-19 Nippon Kayaku Kabushiki Kaisha Novel acetamide derivative and use thereof
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943639A1 (de) 1999-09-13 2001-03-15 Bayer Ag Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
AU3413601A (en) * 2000-02-22 2001-09-03 Daiichi Asubio Pharma Co., Ltd. Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient
AR031176A1 (es) 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10110749A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10110750A1 (de) 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
WO2007120339A1 (en) 2005-12-19 2007-10-25 Genentech, Inc. Pyrimidine kinase inhibitors
WO2007122634A2 (en) * 2006-04-24 2007-11-01 Jubilant Biosys Limited Pyrimidinediones as tyrosine kinase inhibitors
AR061570A1 (es) 2006-06-23 2008-09-03 Smithkline Beecham Corp Compuesto de glicina sustituido en el n heteroaromatico composicion farmaceutica que lo comprende, su uso para preparar un medicamento, procedimientos para preparar dicha composicion farmaceutica y para preparar el compuesto
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
GB0622472D0 (en) 2006-11-10 2006-12-20 Addex Pharmaceuticals Sa Novel heterocyclic derivatives
AU2008219166B2 (en) 2007-02-16 2013-05-16 Amgen Inc. Nitrogen-containing heterocyclyl ketones and their use as c-Met inhibitors
WO2009049112A1 (en) 2007-10-10 2009-04-16 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
DE102008030091B4 (de) 2008-06-25 2011-03-03 Resprotect Gmbh Uracilderivate und deren Verwendung
HRP20170019T1 (hr) 2008-08-15 2017-03-10 Nivalis Therapeutics, Inc. Novi pirol-inhibitori od reduktaze s-nitrozoglutationa kao terapeutska sredstva
UY34451A (es) 2011-11-14 2013-05-31 Cephalon Inc Derivados de uracilo como inhibidores de la quinasa axl y c-met
UA112897C2 (uk) * 2012-05-09 2016-11-10 Байєр Фарма Акцієнгезелльшафт Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань

Similar Documents

Publication Publication Date Title
JP2016535769A5 (OSRAM)
JP2015516000A5 (OSRAM)
RU2010129724A (ru) 4-(4-циано-2-тиоарил)-дигидропиримидиноны и их применение
CA2749040A1 (en) Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
JP2012522814A5 (OSRAM)
JP2016536362A5 (OSRAM)
CA2723559A1 (en) 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use
JP2007524696A5 (OSRAM)
JP2019522628A5 (OSRAM)
JP2010507602A5 (OSRAM)
JP2009515988A5 (OSRAM)
HRP20171189T1 (hr) Bisaril-vezani ariltriazoloni i njihova uporaba
HRP20220899T1 (hr) Spojevi policikličkog karbamoilpiridona i njihova farmaceutska uporaba
JP2011515398A5 (OSRAM)
JP2012528166A5 (OSRAM)
RU2010121763A (ru) Производные пиридазинона и ингибиторы р2х7 рецептора
JP2016525136A5 (OSRAM)
JP2010513272A5 (OSRAM)
PE20140630A1 (es) Derivados de acido 3-fenilpropionico ramificados y su uso
JP2010513322A5 (OSRAM)
JP2010501478A5 (OSRAM)
AR061667A1 (es) Arilamidas sustituidas con tetrazol
JP2014525420A5 (OSRAM)
JP2019518041A5 (OSRAM)
JP2016540742A5 (OSRAM)